CytRx Puts Its Cancer Pipeline to the Test
All told, the Los Angeles-based company could have six to eight trials running simultaneously in the coming months.
cytrx
CytRx at the 2010 OneMedForum
Steven A. Kriegsman, President and CEO of CytRx, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
CytRx to Initiate Clinical Trial for Soft Tissue Cancer Drug
CytRx, a biopharmaceutical research and development company, has announced plans to initiate a Phase II clinical trial for its drug candidate INNO-206 to treat patients who suffer from advanced, treatment-resistant soft tissue sarcoma.